Related Experiment Video

Updated: Aug 19, 2026

Accuracy in Dental Medicine, A New Way to Measure Trueness and Precision
07:57

Accuracy in Dental Medicine, A New Way to Measure Trueness and Precision

Published on: April 29, 2014

Eph receptor B4 is a regulator of estrogen receptor alpha in breast cancer cells

Fee Schmitt1, Phuong-Hien Nguyen, Nibedita Gupta

  • 1Hormones and Signal Transduction Group, German Cancer Research Center, Heidelberg, Germany.

Journal of Receptor and Signal Transduction Research
|June 4, 2013
PubMed
Abstract

Insights

Eph receptor B4 (EphB4) positively regulates estrogen receptor alpha (ER-α) in breast cancer. EphB4 modulates ER-α transcription and protein levels, impacting cancer progression. Akt is identified as a downstream signaling molecule in this pathway.

Area of Science:

  • Molecular oncology
  • Cell signaling
  • Cancer biology

Background:

  • Estrogen receptor alpha (ER-α) is crucial in breast cancer and a therapeutic target.
  • ER-α activity is regulated by various mechanisms, including tyrosine kinase signaling.
  • Previous screens identified Eph receptor tyrosine kinases (Eph) as potential ER-α regulators.

Purpose of the Study:

  • To investigate the role of Eph receptor B4 (EphB4) in regulating ER-α activity in human breast cancer cells.
  • To elucidate the downstream signaling pathway involved in EphB4-mediated ER-α regulation.

Main Methods:

  • Utilized RNA interference to down-regulate EphB4 expression in breast cancer cell lines (MCF-7, T-47D, BT-474).
  • Assessed ER-α transcriptional activity, messenger RNA, and protein expression levels.
  • Analyzed the phosphorylation status of Akt, a downstream signaling molecule.

Main Results:

  • EphB4 was confirmed as a positive regulator of ER-α in human breast cancer cells.
  • EphB4 down-regulation led to impaired estrogen-dependent ER-α transcriptional activity.
  • Silencing EphB4 resulted in decreased ER-α mRNA and protein expression and reduced Akt phosphorylation.

Conclusions:

  • EphB4 acts as an upstream regulator of ER-α in breast cancer by modulating its transcription.
  • The EphB4-ER-α pathway involves Akt as a key downstream signaling molecule.
  • These findings highlight a novel signaling axis with potential therapeutic implications in breast cancer.

More Related Videos

A Standardized Approach to Extra-Oral and Intra-Oral Digital Photography06:49

A Standardized Approach to Extra-Oral and Intra-Oral Digital Photography

Published on: July 22, 2022

Semi-Automated Planimetric Quantification of Dental Plaque Using an Intraoral Fluorescence Camera09:34

Semi-Automated Planimetric Quantification of Dental Plaque Using an Intraoral Fluorescence Camera

Published on: January 27, 2023

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes: